Abstract:Background
Abnormal peripheral immunological features are associated with the progression of coronavirus disease 2019 (COVID-19).
Methods
Clinical and laboratory data were retrieved in a cohort of 146 laboratory-confirmed COVID-19 patients. Potential risk factors for the development of severe COVID-19 were evaluated.
Results
On admission, lymphocytes, CD3+, CD4+ and CD8+ T cells, eosinophils, and albumin and pre-albumin were dramatically lowe… Show more
“…Our study identified that the majority of these well-known pathophysiological elements were associated with disease-related MN in COVID-19 patients, and included older age; anorexia and reduced food intake; respiratory failure; fever during the viral response phase; and catabolic changes due the host inflammatory response phase (increased ferritin and CRP levels, tocilizumab treatment, and higher disease severity). In addition, we observed a considerable reduction in muscle mass and visceral protein markers (albumin, total lymphocytes and cholesterol) at admission, as reported in other studies [41,67]. At discharge, we found significant improvements in levels of CRP, ferritin and T lymphocytes [41,67] and in some nutritional biomarkers that could be related to the favorable progression of the disease.…”
Section: Discussionsupporting
confidence: 87%
“…In addition, we observed a considerable reduction in muscle mass and visceral protein markers (albumin, total lymphocytes and cholesterol) at admission, as reported in other studies [41,67]. At discharge, we found significant improvements in levels of CRP, ferritin and T lymphocytes [41,67] and in some nutritional biomarkers that could be related to the favorable progression of the disease. Our contribution here is the identification of OD at admission as an independent factor for MN during hospitalization of COVID-19 patients.…”
Background and aims
Prevalence and complications of oropharyngeal dysphagia (OD) and malnutrition (MN) in COVID-19 patients is unknown. Our aim was to assess the prevalence, risk factors and clinical outcomes of OD and MN in a general hospital during the first wave of the COVID-19 pandemic.
Methods
This was a prospective, observational study involving clinical assessment of OD (Volume-Viscosity Swallowing Test), and nutritional screening (NRS2002) and assessment (GLIM criteria) in COVID-19 patients hospitalized in general wards at the Consorci Sanitari del Maresme, Catalonia, Spain. The clinical characteristics and outcomes of patients were assessed at pre-admission, admission and discharge, and after 3 and 6-months follow-up.
Results
We included 205 consecutive patients (69.28 ±17.52 years, Charlson 3.74 ±2.62, mean hospital stay 16.8 ±13.0 days). At admission, Barthel Index was 81.3 ±30.3; BMI 28.5 ±5.4 kg/m
2
; OD prevalence 51.7% (44.1% impaired safety of swallow); and 45.5% developed MN with a mean weight loss of 10.1 ±5.0 kg during hospitalization. OD was an independent risk factor for MN during hospitalization (OR 3.96 [1.45–10.75]), and hospitalization was prolonged in patients with MN compared with those without (21.9 ±14.8 vs 11.9 ±8.9 days, respectively; p<0.0001). OD was independently associated with comorbidities, neurological symptoms, and low functionality. At 6-month follow-up, prevalence of OD was still 23.3% and that of MN only 7.1%. Patients with OD at discharge showed reduced 6-month survival than those without OD at discharge (71.6% vs 92.9%, p<0.001); in contrast, those with MN at discharge did not show 6-month survival differences compared to those without (85.4% vs 83.8%, p=0.8).
Conclusions
Prevalence and burden of OD and MN in patients hospitalized in COVID-19 wards is very high. Our results suggest that optimizing the management of MN might shorten the hospitalization period but optimizing the management of OD will likely impact the nutritional status of COVID-19 patients and improve their clinical outcomes and survival after hospital discharge.
ClinicalTrials.gov
Identifier: NCT04346212.
“…Our study identified that the majority of these well-known pathophysiological elements were associated with disease-related MN in COVID-19 patients, and included older age; anorexia and reduced food intake; respiratory failure; fever during the viral response phase; and catabolic changes due the host inflammatory response phase (increased ferritin and CRP levels, tocilizumab treatment, and higher disease severity). In addition, we observed a considerable reduction in muscle mass and visceral protein markers (albumin, total lymphocytes and cholesterol) at admission, as reported in other studies [41,67]. At discharge, we found significant improvements in levels of CRP, ferritin and T lymphocytes [41,67] and in some nutritional biomarkers that could be related to the favorable progression of the disease.…”
Section: Discussionsupporting
confidence: 87%
“…In addition, we observed a considerable reduction in muscle mass and visceral protein markers (albumin, total lymphocytes and cholesterol) at admission, as reported in other studies [41,67]. At discharge, we found significant improvements in levels of CRP, ferritin and T lymphocytes [41,67] and in some nutritional biomarkers that could be related to the favorable progression of the disease. Our contribution here is the identification of OD at admission as an independent factor for MN during hospitalization of COVID-19 patients.…”
Background and aims
Prevalence and complications of oropharyngeal dysphagia (OD) and malnutrition (MN) in COVID-19 patients is unknown. Our aim was to assess the prevalence, risk factors and clinical outcomes of OD and MN in a general hospital during the first wave of the COVID-19 pandemic.
Methods
This was a prospective, observational study involving clinical assessment of OD (Volume-Viscosity Swallowing Test), and nutritional screening (NRS2002) and assessment (GLIM criteria) in COVID-19 patients hospitalized in general wards at the Consorci Sanitari del Maresme, Catalonia, Spain. The clinical characteristics and outcomes of patients were assessed at pre-admission, admission and discharge, and after 3 and 6-months follow-up.
Results
We included 205 consecutive patients (69.28 ±17.52 years, Charlson 3.74 ±2.62, mean hospital stay 16.8 ±13.0 days). At admission, Barthel Index was 81.3 ±30.3; BMI 28.5 ±5.4 kg/m
2
; OD prevalence 51.7% (44.1% impaired safety of swallow); and 45.5% developed MN with a mean weight loss of 10.1 ±5.0 kg during hospitalization. OD was an independent risk factor for MN during hospitalization (OR 3.96 [1.45–10.75]), and hospitalization was prolonged in patients with MN compared with those without (21.9 ±14.8 vs 11.9 ±8.9 days, respectively; p<0.0001). OD was independently associated with comorbidities, neurological symptoms, and low functionality. At 6-month follow-up, prevalence of OD was still 23.3% and that of MN only 7.1%. Patients with OD at discharge showed reduced 6-month survival than those without OD at discharge (71.6% vs 92.9%, p<0.001); in contrast, those with MN at discharge did not show 6-month survival differences compared to those without (85.4% vs 83.8%, p=0.8).
Conclusions
Prevalence and burden of OD and MN in patients hospitalized in COVID-19 wards is very high. Our results suggest that optimizing the management of MN might shorten the hospitalization period but optimizing the management of OD will likely impact the nutritional status of COVID-19 patients and improve their clinical outcomes and survival after hospital discharge.
ClinicalTrials.gov
Identifier: NCT04346212.
“…Longitudinal observation of immune indicators in recovered patients showed that compared with the 2-week follow-up after discharge, lymphocytes and lymphocyte subsets increased, cytokines decreased, and complement series decreased to normal levels at one-year follow-up, except for the abnormal CT group. This is an addition to previous studies reporting that the immune system gradually recovered to a steady state after two weeks of discharge [7] , [17] , [18] , and also reflects the need for long-term follow-up. Interestingly, compared with healthy controls, the normal group had higher NK cell count levels at one-year follow-up, which also suggested that NK cells were a prognostic factor for good recovery of lung function [13] .…”
Section: Discussionsupporting
confidence: 62%
“…There is evidence that complement activation is the pathophysiological basis of many lung diseases, such as asthma and acute respiratory distress syndrome [5] , and also leads to immune-mediated lung injury [6] . Normal immune status was found among COVID-19 recovered subjects 2 weeks after the discharge [7] . However, the long-term immune status of COIVD-19 patients has not been reported in the literature.…”
“…Our previous studies revealed that total lymphocytes, CD3+, CD4+, and CD8+ T cells were dramatically lower among patients with severe COVID-19 than among non-severe patients at admission. These cells returned to normal levels by the second week after discharge, however, lower CD8+ T cell count is an independent risk factor for longer viral positivity duration and is related to an increased risk for discharged patients with SARS-CoV-2 re-positivity ( 9 – 11 ). Pro-inflammatory cytokines and chemokines, such as interleukin (IL)-1β, IL-6, IL-8, tumour necrosis factor (TNF)-α, macrophage inflammatory protein (MIP) 1α/CCL3, interferon (IFN)-γ-induced protein 10 (IP10), monocyte chemoattractant protein 1 (MCP1), granulocyte colony-stimulating factor (G-CSF), and granulocyte-macrophage colony-stimulating factor (GM-CSF), were substantially increased ( 12 , 13 ).…”
COVID-19, the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has threatened public health worldwide. Host antiviral immune responses are essential for viral clearance and disease control, however, remarkably decreased immune cell numbers and exhaustion of host cellular immune responses are commonly observed in patients with COVID-19. This is of concern as it is closely associated with disease severity and poor outcomes. Human leukocyte antigen-G (HLA-G) is a ligand for multiple immune inhibitory receptors, whose expression can be upregulated by viral infections. HLA-G/receptor signalling, such as engagement with immunoglobulin-like transcript 2 (ILT-2) or ILT-4, not only inhibit T and natural killer (NK) cell immune responses, dendritic cell (DC) maturation, and B cell antibody production. It also induces regulatory cells such as myeloid-derived suppressive cells (MDSCs), or M2 type macrophages. Moreover, HLA-G interaction with CD8 and killer inhibitory receptor (KIR) 2DL4 can provoke T cell apoptosis and NK cell senescence. In this context, HLA-G can induce profound immune suppression, which favours the escape of SARS-CoV-2 from immune attack. Although detailed knowledge on the clinical relevance of HLA-G in SARS-CoV-2 infection is limited, we herein review the immunopathological aspects of HLA-G/receptor signalling in SARS-CoV-2 infection, which could provide a better understanding of COVID-19 disease progression and identify potential immunointerventions to counteract SARS-CoV-2 infection.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.